Cellebrite DI Ltd.
CLBT
$19.58
$0.020.10%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 325.11M | 306.12M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 325.11M | 306.12M | |
| Cost of Revenue | -- | -- | 53.23M | 50.45M | |
| Gross Profit | -- | -- | 271.88M | 255.67M | |
| SG&A Expenses | -- | -- | 154.26M | 145.39M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 291.87M | 278.20M | |
| Operating Income | -- | -- | 33.24M | 27.91M | |
| Income Before Tax | -- | -- | -75.56M | -54.12M | |
| Income Tax Expenses | -- | -- | 5.54M | 5.26M | |
| Earnings from Continuing Operations | -- | -- | -81.10 | -59.38 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -81.10M | -59.38M | |
| EBIT | -- | -- | 33.24M | 27.91M | |
| EBITDA | -- | -- | 43.25M | 38.32M | |
| EPS Basic | -- | -- | -0.43 | -0.34 | |
| Normalized Basic EPS | -- | -- | -0.14 | -0.07 | |
| EPS Diluted | -- | -- | -0.45 | -0.35 | |
| Normalized Diluted EPS | -- | -- | -0.14 | -0.07 | |
| Average Basic Shares Outstanding | -- | -- | 760.48M | 750.99M | |
| Average Diluted Shares Outstanding | -- | -- | 773.30M | 771.65M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |